Skip to main content
Log in

Effect of sinomenine on vascular smooth muscle cell dedifferentiation and neointima formation after vascular injury in mice

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Sinomenine, a pure alkaloid extract from Sinomenium acutum, has anti-inflammatory and immunoregulatory functions. This study investigated the efficiency and the signalling pathways involved in the effect of sinomenine on vascular smooth muscle cell (VSMC) dedifferentiation in response to platelet-derived growth factor (PDGF)-BB stimulation and vascular injury. VSMCs were isolated from rat aorta and preincubated with sinomenine before being stimulated with PDGF-BB. WST and BrdU incorporation assays were used to evaluate VSMC proliferation. Flow cytometric analysis was performed for testing the cell cycle progression. The cell migration of VSMCs were analysed using a Transwell system. The expression of VSMC specific genes and signalling proteins were tested by Western blot. For the animal study, C57/BL6 mice were fed either normal rodent chow diets or sinomenine chow diets that supplemented with 0.09 % sinomenine (w/w) in the normal chows for 14 days before carotid artery wire injury. PDGF-BB activated the dedifferentiation of VSMCs characterised by decreased expression of SMA, Smoothelin and SM22α. However, sinomenine treatment preserved the dedifferentiation in response to PDGF-BB. The activations of mitogen-activated protein kinase extracellular signal-regulated kinases, Akt, GSK3β and STAT3 induced by PDGF-BB were also inhibited in sinomenine-treated VSMCs. In vivo evidence with wire-injured mice exhibited a reduction in neointimal area and an increase in smooth muscle-specific gene expression in the sinomenine-treated group. In this study, we found that sinomenine-suppressed VSMC phenotype switching induced by PDGF-BB in vitro and neointimal formation in vivo. Therefore, sinomenine is a potential candidate to be used in the treatment of vascular proliferative disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Doran AC, Meller N, McNamara CA (2008) Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28:812–819

    Article  PubMed  CAS  Google Scholar 

  2. Owens GK, Kumar MS, Wamhoff BR (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84:767–801

    Article  PubMed  CAS  Google Scholar 

  3. Hao H, Gabbiani G, Bochaton-Piallat ML (2003) Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 23:1510–1520

    Article  PubMed  CAS  Google Scholar 

  4. Mack CP (2011) Signaling mechanisms that regulate smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 31:1495–1505

    Article  PubMed  CAS  Google Scholar 

  5. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460:705–710

    PubMed  CAS  Google Scholar 

  6. Wang Q, Li XK (2011) Immunosuppressive and anti-inflammatory activities of sinomenine. Int Immunopharmacol 11:373–376

    Article  PubMed  CAS  Google Scholar 

  7. Long LH, Wu PF, Chen XL, Zhang Z, Chen Y, Li YY, Jin Y, Chen JG, Wang F (2010) HPLC and LC-MS analysis of sinomenine and its application in pharmacokinetic studies in rats. Acta Pharmacol Sin 31:1508–1514

    Article  PubMed  CAS  Google Scholar 

  8. Yamasaki H (1976) Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum. Acta Med Okayama 30:1–20

    PubMed  CAS  Google Scholar 

  9. Cheng Y, Zhang J, Hou W, Wand D, Li F, Zhang Y, Yuan F (2009) Immunoregulatory effects of sinomenine on the T-bet/GATA-3 ratio and Th1/Th2 cytokine balance in the treatment of mesangial proliferative nephritis. Int Immunopharmacol 9:894–899

    Article  PubMed  CAS  Google Scholar 

  10. Liu L, Resch K, Kaever V (1994) Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine. Int J Immunopharmacol 16:685–691

    Article  PubMed  CAS  Google Scholar 

  11. Hojo H, Kondo Y, Umeda H, Tahira T, Hashimoto Y (1985) Effect of sinomenine on antibody responses in mice. J Immunopharmacol 7:33–42

    Article  PubMed  CAS  Google Scholar 

  12. Kim HM, Moon PD, Chae HJ, Kim HR, Chung JG, Kim JJ, Lee EJ (2000) The stem of Sinomenium acutum inhibits mast cell-mediated anaphylactic reactions and tumor necrosis factor-alpha production from rat peritoneal mast cells. J Ethnopharmacol 70:135–141

    Article  PubMed  CAS  Google Scholar 

  13. Nishida S, Satoh H (2006) In vitro pharmacological actions of sinomenine on the smooth muscle and the endothelial cell activity in rat aorta. Life Sci 79:1203–1206

    Article  PubMed  CAS  Google Scholar 

  14. Wang L, Zhu LH, Jiang H, Tang QZ, Yan L, Wang D, Liu C, Bian ZY, Li H (2010) Grape seed proanthocyanidins attenuate vascular smooth muscle cell proliferation via blocking phosphatidylinositol 3-kinase-dependent signaling pathways. J Cell Physiol 223:713–726

    PubMed  CAS  Google Scholar 

  15. Zhu LH, Wang L, Wang D, Jiang H, Tang QZ, Yan L, Bian ZY, Wang XA, Li H (2010) Puerarin attenuates high-glucose-and diabetes-induced vascular smooth muscle cell proliferation by blocking PKCbeta2/Rac1-dependent signaling. Free Radic Biol Med 48:471–482

    Article  PubMed  CAS  Google Scholar 

  16. Li L, Zhang HN, Chen HZ, Gao P, Zhu LH, Li HL, Lv X, Zhang QJ, Zhang R, Wang Z, She ZG, Zhang R, Wei YS, Du GH, Liu DP, Liang CC (2011) SIRT1 acts as a modulator of neointima formation following vascular injury in mice. Circ Res 108:1180–1189

    Article  PubMed  CAS  Google Scholar 

  17. Jiang T, Zhou L, Zhang W, Qu D, Xu X, Yang Y, Li S (2010) Effects of sinomenine on proliferation and apoptosis in human lung cancer cell line NCI-H460 in vitro. Mol Med Report 3:51–56

    PubMed  CAS  Google Scholar 

  18. Shu L, Yin W, Zhang J, Tang B, Kang YX, Ding F, Hua ZC (2007) Sinomenine inhibits primary CD4 + T-cell proliferation via apoptosis. Cell Biol Int 31:784–789

    Article  PubMed  CAS  Google Scholar 

  19. He X, Wang J, Guo Z, Liu Q, Chen T, Wang X, Cao X (2005) Requirement for ERK activation in sinomenine-induced apoptosis of macrophages. Immunol Lett 98:91–96

    Article  PubMed  CAS  Google Scholar 

  20. Wang Z, Wang DZ, Hockemeyer D, McAnally J, Nordheim A, Olson EN (2004) Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428:185–189

    Article  PubMed  CAS  Google Scholar 

  21. Hayashi K, Takahashi M, Nishida W, Yoshida K, Ohkawa Y, Kitabatake A, Aoki J, Arai H, Sobue K (2001) Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ Res 89:251–258

    Article  PubMed  CAS  Google Scholar 

  22. Yamaguchi H, Igarashi M, Hirata A, Sugae N, Tsuchiya H, Jimbu Y, Tominaga M, Kato T (2004) Altered PDGF-BB-induced p38 MAP kinase activation in diabetic vascular smooth muscle cells: roles of protein kinase C-delta. Arterioscler Thromb Vasc Biol 24:2095–2101

    Article  PubMed  CAS  Google Scholar 

  23. Yu K, Zheng B, Han M, Wen JK (2011) ATRA activates and PDGF-BB represses the SM22α promoter through KLF4 binding to, or dissociating from, its cis-DNA elements. Cardiovasc Res 90:464–474

    Article  PubMed  CAS  Google Scholar 

  24. Miyake H, Maeda K, Asai N, Shibata R, Ichimiya H, Isotani-Sakakibara M, Yamamura Y, Kato K, Enomoto A, Takahashi M, Murohara T (2011) The actin-binding protein Girdin and its Akt-mediated phosphorylation regulate neointima formation after vascular injury. Circ Res 108:1170–1179

    Article  PubMed  CAS  Google Scholar 

  25. Hegner B, Lange M, Kusch A, Essin K, Sezer O, Schulze-Lohoff E, Luft FC, Gollasch M, Dragun D (2009) mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors. Arterioscler Thromb Vasc Biol 29:232–238

    Article  PubMed  CAS  Google Scholar 

  26. Hayashi K, Takahashi M, Nishida W, Yoshida K, Ohkawa Y, Kitabatake A, Aoki J, Arai H, Sobue K (2001) Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ Res 89:251–258

    Article  PubMed  CAS  Google Scholar 

  27. Kaimoto T, Yasuda O, Ohishi M, Mogi M, Takemura Y, Suhara T, Ogihara T, Fukuo K, Rakugi H (2010) Nifedipine inhibits vascular smooth muscle cell dedifferentiation via downregulation of Akt signaling. Hypertension 56:247–252

    Article  PubMed  CAS  Google Scholar 

  28. Deb A, Zamanian-Daryoush M, Xu Z, Kadereit S, Williams BR (2001) Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3. The EMBO 20:2487–2496

    Article  CAS  Google Scholar 

  29. Wang D, Liu Z, Li Q, Karpurapu M, Kundumani-Sridharan V, Cao H, Dronadula N, Rizvi F, Bajpai AK, Zhang C, Müller-Newen G, Harris KW, Rao GN (2007) An essential role for gp130 in neointima formation following arterial injury. Circ Res 100:807–816

    Article  PubMed  CAS  Google Scholar 

  30. Seki Y, Kai H, Shibata R, Nagata T, Yasukawa H, Yoshimura A, Imaizumi T (2000) Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury. Circ Res 87:12–18

    Article  PubMed  CAS  Google Scholar 

  31. Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22:1276–1312

    Article  PubMed  CAS  Google Scholar 

  32. Wang YZ, Wharton W, Garcia R, Kraker A, Jove R, Pledger WJ (2000) Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity. Oncogene 19:2075–2085

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from Major Subject of Health Department of Hubei Province of China (No. JX4A02); The National Natural Science Foundation (No. 81000342); and Natural Science Foundation of Hubei Province of China; (No. 2010CDB06203).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hong Jiang.

Additional information

Lihua Zhu and Yarong Hao contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, L., Hao, Y., Guan, H. et al. Effect of sinomenine on vascular smooth muscle cell dedifferentiation and neointima formation after vascular injury in mice. Mol Cell Biochem 373, 53–62 (2013). https://doi.org/10.1007/s11010-012-1474-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-012-1474-9

Keywords

Navigation